Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 32 | 2018 | 69 | 5.190 |
Why?
|
| Headache | 34 | 2017 | 78 | 4.480 |
Why?
|
| Behavior Therapy | 18 | 2015 | 107 | 2.940 |
Why?
|
| Tension-Type Headache | 12 | 2015 | 14 | 2.310 |
Why?
|
| Headache Disorders | 14 | 2012 | 17 | 1.770 |
Why?
|
| Stress, Psychological | 12 | 2017 | 233 | 1.280 |
Why?
|
| Biofeedback, Psychology | 9 | 2015 | 12 | 1.140 |
Why?
|
| Research Design | 12 | 2013 | 337 | 1.050 |
Why?
|
| Mental Disorders | 9 | 2009 | 127 | 1.020 |
Why?
|
| Humans | 87 | 2020 | 34562 | 0.760 |
Why?
|
| Exercise | 4 | 2017 | 701 | 0.690 |
Why?
|
| Biomedical Research | 4 | 2018 | 186 | 0.660 |
Why?
|
| Headache Disorders, Primary | 2 | 2009 | 3 | 0.560 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 922 | 0.520 |
Why?
|
| Pain | 4 | 2012 | 330 | 0.490 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 183 | 0.480 |
Why?
|
| Back Pain | 4 | 2020 | 32 | 0.460 |
Why?
|
| Relaxation Therapy | 6 | 2015 | 13 | 0.420 |
Why?
|
| Clinical Trials as Topic | 4 | 2005 | 326 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 565 | 0.410 |
Why?
|
| Models, Biological | 1 | 2015 | 432 | 0.390 |
Why?
|
| Exercise Therapy | 1 | 2015 | 283 | 0.390 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 91 | 0.360 |
Why?
|
| Chronic Disease | 11 | 2010 | 439 | 0.340 |
Why?
|
| Anxiety Disorders | 3 | 2008 | 81 | 0.330 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 78 | 0.310 |
Why?
|
| Research | 5 | 2005 | 88 | 0.310 |
Why?
|
| Models, Theoretical | 3 | 2017 | 146 | 0.300 |
Why?
|
| Adult | 32 | 2019 | 10030 | 0.290 |
Why?
|
| Depressive Disorder | 2 | 2008 | 76 | 0.270 |
Why?
|
| Comorbidity | 6 | 2012 | 596 | 0.270 |
Why?
|
| Sleep | 1 | 2008 | 90 | 0.260 |
Why?
|
| Manipulation, Osteopathic | 1 | 2007 | 1 | 0.260 |
Why?
|
| Relaxation | 1 | 2007 | 9 | 0.260 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2007 | 24 | 0.260 |
Why?
|
| Patient Selection | 2 | 2005 | 291 | 0.250 |
Why?
|
| Double-Blind Method | 2 | 2005 | 597 | 0.240 |
Why?
|
| Sexuality | 1 | 2006 | 14 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 2 | 2006 | 431 | 0.230 |
Why?
|
| Pain Measurement | 6 | 2019 | 385 | 0.230 |
Why?
|
| Neuropsychology | 1 | 2005 | 3 | 0.230 |
Why?
|
| Middle Aged | 26 | 2019 | 12726 | 0.230 |
Why?
|
| Neuropsychological Tests | 2 | 2005 | 372 | 0.220 |
Why?
|
| Sexual Behavior | 1 | 2006 | 129 | 0.220 |
Why?
|
| Psychotherapy | 3 | 2019 | 20 | 0.220 |
Why?
|
| Cognition | 2 | 2008 | 576 | 0.220 |
Why?
|
| Female | 32 | 2019 | 21532 | 0.220 |
Why?
|
| Adolescent | 12 | 2017 | 3805 | 0.220 |
Why?
|
| Chest Pain | 1 | 2007 | 232 | 0.210 |
Why?
|
| Male | 30 | 2019 | 20740 | 0.200 |
Why?
|
| Electroencephalography | 1 | 2003 | 76 | 0.190 |
Why?
|
| Psychotherapy, Group | 1 | 2002 | 17 | 0.180 |
Why?
|
| Placebos | 1 | 2002 | 69 | 0.180 |
Why?
|
| Caffeine | 1 | 2002 | 29 | 0.180 |
Why?
|
| Treatment Outcome | 8 | 2020 | 3623 | 0.180 |
Why?
|
| Disease Progression | 4 | 2017 | 634 | 0.180 |
Why?
|
| Central Nervous System Stimulants | 1 | 2002 | 85 | 0.170 |
Why?
|
| Recurrence | 8 | 2005 | 296 | 0.170 |
Why?
|
| Telemedicine | 2 | 2019 | 120 | 0.160 |
Why?
|
| Patient Compliance | 3 | 2006 | 218 | 0.160 |
Why?
|
| Low Back Pain | 1 | 2020 | 47 | 0.160 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 939 | 0.150 |
Why?
|
| Cluster Analysis | 2 | 1999 | 128 | 0.150 |
Why?
|
| Nurses | 1 | 2019 | 14 | 0.150 |
Why?
|
| Bioethics | 1 | 2018 | 2 | 0.150 |
Why?
|
| Authorship | 1 | 2018 | 9 | 0.150 |
Why?
|
| Publications | 1 | 2018 | 9 | 0.150 |
Why?
|
| Minority Groups | 1 | 2018 | 90 | 0.140 |
Why?
|
| Health Personnel | 1 | 2019 | 131 | 0.130 |
Why?
|
| Poverty | 1 | 2018 | 118 | 0.130 |
Why?
|
| Telephone | 1 | 2018 | 67 | 0.130 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 145 | 0.120 |
Why?
|
| Population Surveillance | 2 | 2017 | 133 | 0.120 |
Why?
|
| Remission Induction | 2 | 2013 | 97 | 0.120 |
Why?
|
| Risk Factors | 7 | 2013 | 4137 | 0.120 |
Why?
|
| Secondary Prevention | 2 | 2009 | 74 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 4 | 2005 | 48 | 0.120 |
Why?
|
| Aged | 11 | 2019 | 11022 | 0.110 |
Why?
|
| Depression | 4 | 2019 | 458 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2005 | 508 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 803 | 0.110 |
Why?
|
| Young Adult | 4 | 2017 | 2831 | 0.110 |
Why?
|
| Prevalence | 3 | 2013 | 1034 | 0.110 |
Why?
|
| Socioenvironmental Therapy | 1 | 1994 | 1 | 0.100 |
Why?
|
| Propranolol | 2 | 1991 | 18 | 0.100 |
Why?
|
| Thinking | 1 | 2013 | 6 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 50 | 0.100 |
Why?
|
| Complementary Therapies | 1 | 2014 | 80 | 0.100 |
Why?
|
| Precipitating Factors | 1 | 2013 | 2 | 0.100 |
Why?
|
| Data Collection | 1 | 2013 | 191 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2013 | 168 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 194 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 211 | 0.090 |
Why?
|
| United States | 2 | 2018 | 4278 | 0.090 |
Why?
|
| Forecasting | 2 | 2017 | 153 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 115 | 0.080 |
Why?
|
| Health Expenditures | 1 | 2011 | 71 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 1607 | 0.080 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2010 | 6 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 1990 | 58 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2011 | 191 | 0.080 |
Why?
|
| Analgesics | 1 | 2011 | 117 | 0.080 |
Why?
|
| Muscle Contraction | 3 | 2008 | 183 | 0.080 |
Why?
|
| Home Nursing | 1 | 2009 | 9 | 0.080 |
Why?
|
| Anxiety | 2 | 2009 | 206 | 0.070 |
Why?
|
| Electromyography | 2 | 2008 | 68 | 0.070 |
Why?
|
| North Carolina | 1 | 2012 | 1613 | 0.070 |
Why?
|
| Persuasive Communication | 1 | 2007 | 4 | 0.060 |
Why?
|
| Truth Disclosure | 1 | 2007 | 15 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2007 | 176 | 0.060 |
Why?
|
| Heart Rate | 3 | 1985 | 372 | 0.060 |
Why?
|
| Personality Inventory | 3 | 2003 | 17 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2006 | 24 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2006 | 32 | 0.060 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2006 | 28 | 0.060 |
Why?
|
| Serotonin | 1 | 2006 | 49 | 0.060 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2006 | 55 | 0.060 |
Why?
|
| Hormones | 1 | 2005 | 26 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2005 | 68 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2005 | 60 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 188 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2006 | 182 | 0.060 |
Why?
|
| Psychological Tests | 1 | 1985 | 34 | 0.060 |
Why?
|
| Time Factors | 5 | 2013 | 2353 | 0.050 |
Why?
|
| Arousal | 2 | 1994 | 20 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 76 | 0.050 |
Why?
|
| Photophobia | 2 | 2005 | 2 | 0.050 |
Why?
|
| Coronary Disease | 2 | 1996 | 239 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 356 | 0.050 |
Why?
|
| Nausea | 2 | 2005 | 55 | 0.050 |
Why?
|
| Periodicity | 1 | 2002 | 11 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2019 | 262 | 0.050 |
Why?
|
| Animals | 3 | 2010 | 8579 | 0.050 |
Why?
|
| Women's Health | 2 | 2002 | 242 | 0.050 |
Why?
|
| Lead Poisoning | 1 | 1982 | 3 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 390 | 0.050 |
Why?
|
| Saliva | 1 | 2002 | 41 | 0.050 |
Why?
|
| Affect | 1 | 2002 | 72 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2002 | 74 | 0.040 |
Why?
|
| Hand | 1 | 2002 | 80 | 0.040 |
Why?
|
| Reaction Time | 1 | 2002 | 131 | 0.040 |
Why?
|
| Diagnosis-Related Groups | 1 | 2001 | 10 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 116 | 0.040 |
Why?
|
| Learning | 1 | 1982 | 88 | 0.040 |
Why?
|
| Psychometrics | 2 | 1996 | 143 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 261 | 0.040 |
Why?
|
| Desipramine | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 1910 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 755 | 0.040 |
Why?
|
| Societies, Medical | 2 | 1999 | 168 | 0.040 |
Why?
|
| Self Care | 2 | 2006 | 144 | 0.040 |
Why?
|
| Hyperacusis | 1 | 1999 | 1 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1393 | 0.040 |
Why?
|
| Vomiting | 1 | 1999 | 23 | 0.040 |
Why?
|
| Scientific Misconduct | 1 | 2018 | 4 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2018 | 36 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 28 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 1999 | 272 | 0.030 |
Why?
|
| Sick Role | 2 | 1996 | 7 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2002 | 901 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2018 | 214 | 0.030 |
Why?
|
| Progesterone | 2 | 2002 | 112 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 614 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 98 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2001 | 53 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 267 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 245 | 0.030 |
Why?
|
| Child | 1 | 2003 | 2614 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 349 | 0.030 |
Why?
|
| Overweight | 1 | 2017 | 289 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2017 | 184 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2012 | 3825 | 0.030 |
Why?
|
| International Cooperation | 2 | 2012 | 33 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1994 | 24 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 380 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2002 | 542 | 0.030 |
Why?
|
| Probability | 1 | 2013 | 168 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2367 | 0.020 |
Why?
|
| Menstruation Disturbances | 1 | 1992 | 5 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 510 | 0.020 |
Why?
|
| Parturition | 1 | 2012 | 11 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 703 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2012 | 40 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 138 | 0.020 |
Why?
|
| Poloxalene | 1 | 2011 | 1 | 0.020 |
Why?
|
| Estradiol | 1 | 1992 | 156 | 0.020 |
Why?
|
| Drug Costs | 1 | 2011 | 51 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1992 | 136 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 113 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 590 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 1990 | 28 | 0.020 |
Why?
|
| Ergotamine | 1 | 1989 | 1 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1246 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 808 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2005 | 305 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 1069 | 0.020 |
Why?
|
| Internal-External Control | 2 | 1985 | 17 | 0.020 |
Why?
|
| Headache Disorders, Secondary | 1 | 2007 | 2 | 0.020 |
Why?
|
| Sex Factors | 2 | 2002 | 708 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2007 | 14 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 1996 | 823 | 0.020 |
Why?
|
| Smoking | 1 | 1991 | 544 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2006 | 22 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2006 | 23 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2006 | 79 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 197 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 24 | 0.010 |
Why?
|
| Environment | 1 | 1985 | 51 | 0.010 |
Why?
|
| Prognosis | 2 | 2005 | 1606 | 0.010 |
Why?
|
| Personality Disorders | 1 | 2005 | 5 | 0.010 |
Why?
|
| Observation | 1 | 2005 | 25 | 0.010 |
Why?
|
| Sample Size | 1 | 2005 | 40 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 230 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2005 | 76 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 111 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 81 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 193 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1982 | 34 | 0.010 |
Why?
|
| Locomotion | 1 | 1982 | 37 | 0.010 |
Why?
|
| Prejudice | 1 | 2002 | 51 | 0.010 |
Why?
|
| Pain Clinics | 1 | 2001 | 1 | 0.010 |
Why?
|
| Migraine without Aura | 1 | 2001 | 1 | 0.010 |
Why?
|
| Migraine with Aura | 1 | 2001 | 2 | 0.010 |
Why?
|
| Social Class | 1 | 2002 | 94 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2001 | 53 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 95 | 0.010 |
Why?
|
| Estrogens | 1 | 2002 | 210 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 2463 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2002 | 260 | 0.010 |
Why?
|
| Vascular Headaches | 1 | 1998 | 1 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1982 | 657 | 0.010 |
Why?
|
| Rats | 1 | 1982 | 1946 | 0.010 |
Why?
|
| Type A Personality | 1 | 1996 | 1 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1996 | 45 | 0.010 |
Why?
|
| Continental Population Groups | 1 | 1998 | 245 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1996 | 96 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1994 | 79 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1994 | 112 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 4157 | 0.010 |
Why?
|
| Software Validation | 1 | 1992 | 4 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 43 | 0.010 |
Why?
|
| Quality of Life | 1 | 1998 | 1032 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1991 | 84 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1992 | 585 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1994 | 515 | 0.000 |
Why?
|